JMIR Publications

ABSTRACT

Background:

Mobile apps are increasingly being used to manage cancer, however not without challenges. Despite their potential, evidence on the actual use of mobile technologies within the cancer care context is not adequate. Areas of concern include healthcare professionals’ (HCP) challenges in identifying the most suitable applications for their specific needs, as well as in evaluating these apps' quality and clinical effectiveness.

Objective:

The present study aims to: (a) map the landscape of free mobile apps for cancer prevention, treatment, therapy, or support for HCPs, and (b) assess the quality of the applications identified

Methods:

A systematic search of apps in Google Play and the AppStore was conducted according to predefined keywords words and applying the PRISMA guidelines. Searches were performed in May 2023 and November 2024. Apps were independently assessed by two reviewers using the Mobile App Rating Scale (MARS).

Results:

The search identified 221 apps. After the screening phase, 20 mobile apps that met the inclusion criteria were evaluated and prioritized by MARS peer review. The mean score was 3.51, with only two applications exceeding the 4-point threshold, which is considered to indicate a ‘good’ level of quality

Conclusions:

This study provides a ranking of cancer-related apps for HCPs, detailing the strengths and limitations of each to aid in curating useful digital resources. Despite the generally low quality observed, the ONCOassist app showed notable potential utility. The findings underscore a lack of robust evidence in current literature supporting the effectiveness of health apps for cancer care.